Have a feature idea you'd love to see implemented? Let us know!
Back to ANIP overview

ANIP Ani Pharmaceuticals PE ratio, current and historical analysis

The PE ratio for Ani Pharmaceuticals stock stands at 50.92 as of Oct 22, 2024. This results from the current EPS of $1.18 and stock price of $60.08. A decrease of 25% has been seen in the P/E ratio compared to the average of 67.6 of the last 4 quarters.

ANIP PE ratio history

How has ANIP's PE ratio performed in the past

Over the last ten years, the average PE ratio of Ani Pharmaceuticals has been 433.97. The current 50.92 PE ratio is 88% below the historical average. Over the past ten years, ANIP's PE ratio was at its highest in the Jun 2018 quarter at 6,680, with a price of $66.8 and an EPS of $0.01. The Sep 2015 quarter recorded the bottom point at 13.21, with a price of $39.51 and an EPS of $2.99.

Average
433.97
Median
60.29
Minimum
13.21
Maximum
6,680

Ani Pharmaceuticals PE ratio by year

Maximum annual increase: 429.36% in 2016

Year PE ratio Change
2023 64.12 N/A
2022 N/A N/A
2021 N/A N/A
2020 N/A N/A
2019 120.92 251.82%
2018 34.37 N/A
2017 N/A N/A
2016 178.29 429.36%
2015 33.68 55.85%
2014 21.61 N/A

ANIP average PE ratio chart

What is the average PE ratio of ANIP for the past years

Currently, ANIP's PE ratio is below the 5 and 10-year averages.

3-year avg
N/A
5-year avg
78.25
10-year avg
433.97
15-year avg
400.66

ANIP PE vs peers

What is ANIP's PE ratio compared to its peers

ANIP's PE ratio is higher than its peer stocks NVS and CAH. Ani Pharmaceuticals's current PE ratio of 50.92 is above the average of its peers, which is 20.72.

Stock name PE ratio Market cap
NVS Novartis AG 14.44 $232.75B
JAZZ Jazz Pharmaceuticals plc 17.69 $6.86B
RPRX Royalty Pharma plc 18.12 $16.24B
CAH Cardinal Health Inc 32.16 $27.29B
ANIP Ani Pharmaceuticals Inc 50.11 $1.24B
TEVA Teva Pharmaceutical Industries Ltd N/A $20.86B
CLDX Celldex Therapeutics Inc N/A $1.9B
PFE Pfizer Inc N/A $163.54B

Frequently asked questions

What is Ani Pharmaceuticals's PE ratio?

ANIP's price to earnings ratio is 50.92 as of Oct 22, 2024.

What is the 5-year average PE ratio for Ani Pharmaceuticals (ANIP)?

The 5-year average PE ratio for ANIP stock is 78.25.

What is the highest PE ratio for ANIP?

Over the last ten years, the quarterly PE ratio reached a historic high of 6,680 in the Jun 2018 quarter.

How does the current PE ratio for ANIP compare to its historical average?

ANIP's price to earnings ratio is currently 88% below its 10-year historical average.

How is ANIP's PE ratio calculated (Ani Pharmaceuticals PE ratio formula)?

The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Oct 22, 2024), Ani Pharmaceuticals's stock price is $60.08. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $1.18. Therefore, Ani Pharmaceuticals's P/E ratio for today is 50.92. PE RATIO(50.92) = STOCK PRICE($60.08) / TTM EPS($1.18)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.